defect
transcript
factor
recent
identifi
overlap
phenotyp
associ
myeloid
malign
dendrit
cell
monocyt
b
nkcell
defici
monomac
syndrom
monocytopenia
mycobacterium
avium
complex
infect
emberg
syndrom
earli
onset
primari
lymphedema
multipl
wart
sensorineur
deaf
dysmorph
famili
mdsaml
addit
known
phenotyp
syndrom
share
autosomaldomin
inherit
variabl
manifest
immunodefici
respiratori
tract
frequent
affect
viral
fungal
mycobacteri
infect
chronic
lung
tissu
chang
pulmonari
alveolar
proteinosi
pap
well
pulmonari
arteri
hypertens
describ
adult
patient
present
adolesc
male
defici
earli
manifest
diffus
parenchym
lung
diseas
dpld
well
atyp
cours
epsteinbarr
viru
ebv
infect
caucasian
male
present
hospit
acut
fever
malais
headach
cough
dyspnea
bilater
pneumonia
sign
system
inflamm
correspond
bacteri
infect
creactiv
protein
mgl
diagnos
antibiot
treatment
initi
caus
microorgan
identifi
despit
rapid
clinic
improv
chest
xray
show
persist
interstiti
chang
figur
subsequ
highresolut
comput
tomographi
hrct
reveal
mark
lung
damag
suggest
bronchiectasi
peribronch
fibrotis
subpleur
cystic
remodel
honeycomb
emphysema
figur
interestingli
pulmonari
function
test
show
normal
vital
capac
total
lung
capac
well
diffus
capac
tabl
thu
detect
chronic
lung
chang
function
correl
first
episod
pneumonia
previous
healthi
boy
investig
unfold
caus
diffus
parenchym
lung
diseas
initi
complet
blood
count
show
leukocytopenia
mark
monocytopenia
tabl
immunolog
assay
detect
bcell
lymphopenia
predomin
memori
b
cell
despit
low
number
b
cell
normal
serum
immunoglobulin
level
igm
iga
increas
level
igg
present
gl
antibodi
respons
routin
vaccin
normal
serum
autoantibodi
found
function
test
granulocyt
respiratori
burst
test
analysi
abil
granulocyt
releas
reactiv
oxygen
speci
vitro
stimul
cell
evalu
prolif
respons
cell
variou
vitro
stimuli
exclud
chronic
granulomat
diseas
tcell
prolifer
defect
serolog
correspond
primari
ebv
infect
tabl
howev
ebv
viral
load
peripher
blood
low
bronchoalveolar
lavag
bal
show
ebv
presenc
bronchial
fluid
immunolog
analysi
bal
fluid
show
lymphocytosi
predomin
increas
hladr
express
especi
alveolar
macrophag
present
cell
detect
pa
period
posit
materi
evid
alveolar
macrophag
tabl
neither
bacteri
fungal
mycobacteri
includ
nontubercul
mycobacteria
viral
cytomegaloviru
human
herp
viru
varicella
zoster
viru
human
herp
viru
respiratori
syntiti
viru
influenza
adenoviru
enteroviru
coronaviru
parainfluenza
human
rhinoviru
human
metapneumoviru
bokaviru
papillomaviru
test
infect
reveal
via
cultur
serolog
molecular
genet
test
peripher
blood
bronchoalveolar
fluid
henc
extens
microbiolog
analysi
reveal
presenc
ebv
peripher
blood
lung
histopatholog
investig
lung
parenchyma
prompt
thoracoscop
lung
biopsi
sever
affect
region
right
upper
lobe
show
fibrosi
cystic
rearrang
cholesterol
cleft
sign
organ
pneumonia
vascul
figur
c
inflammatori
infiltr
predominantli
lymphoplasmocyt
presenc
activ
macrophag
chang
compat
pulmonari
alveolar
proteinosi
alveolar
fill
disord
seen
despit
ebv
presenc
genom
equival
ge
lung
tissu
found
polymeras
chain
reaction
hybrid
probe
ebvencod
small
rna
eber
neg
histolog
slide
thu
clear
relationship
ebv
histopatholog
parenchym
chang
could
state
given
sever
afflict
lung
parenchyma
fibrot
remodel
ongo
inflamm
activ
cell
bronchoalveolar
fluid
lack
clear
evid
infecti
caus
treatment
oral
steroid
initi
suppress
tissu
destruct
prophylact
antibiot
azithromycin
ad
patient
close
monitor
immunoglobulin
level
normal
sign
system
inflamm
regress
month
stabl
find
document
via
hrct
clinic
symptom
present
ebv
viral
load
remain
low
peripher
blood
minim
presenc
viru
seen
repeat
bal
howev
serolog
sign
activ
ebv
infect
persist
ebna
antibodi
detect
follow
lymphoprolifer
present
patient
remain
asymptomat
condit
classifi
persist
ebv
viremia
accompani
atyp
serolog
respons
molecular
genet
test
carri
normal
result
exclud
xlink
lymphoprolif
diseas
common
inborn
caus
abnorm
immunolog
reaction
ebv
infect
detail
possibl
genet
caus
yet
test
patient
discuss
patient
histori
occasion
uncompl
respiratori
infect
age
year
suffer
acut
bronchiti
chest
xray
perform
retrospect
analysi
imag
show
interstiti
chang
present
alreadi
time
monocytopenia
document
earli
age
year
persist
profound
monocytopenia
b
lymphocytopenia
follow
prompt
sequenc
diagnosi
defici
confirm
find
known
heterozyg
pathogen
variat
c
myeloid
malign
exclud
morpholog
flow
cytometr
cytogenet
analysi
bone
marrow
aspir
detail
immunophenotyp
analysi
bone
marrow
show
suppress
precursor
impair
bcell
lineag
b
cell
present
plasma
cell
constitut
matur
cell
precursor
scarc
lower
percentag
monocyt
well
progenitor
addit
test
show
lack
myeloid
plasmacytoid
dendrit
cell
immunosuppress
treatment
stop
patient
treat
prophylact
antibiot
antimycot
vaccin
human
papillomaviru
hpv
perform
recommend
monitor
close
includ
regular
check
bone
marrow
aspir
earli
detect
clonal
myeloid
prolifer
case
myelodysplasia
transplant
hematopoiet
stem
cell
would
initi
two
year
followup
patient
develop
clinic
symptom
treat
pseudomona
aeruginosa
found
bronchoalveolar
fluid
detect
second
bal
analysi
perform
month
first
one
otherwis
clinic
sign
increas
suscept
infect
pulmonari
function
test
remain
normal
progress
pulmonari
parenchyma
afflict
detect
far
tabl
heterozyg
mutat
found
patient
brother
yearold
father
wherea
mother
healthi
brother
without
clinic
symptom
far
blood
test
reveal
leukocytopenia
mark
monocytopenia
hrct
scan
show
normal
parenchyma
ebv
activ
document
father
suffer
bilater
ankylos
spondyl
posit
apart
low
bcell
number
cell
lymphocyt
prevail
memori
phenotyp
cell
b
cell
norm
leukocyt
count
abnorm
detect
lymphocyt
chang
three
famili
member
carri
mutat
stimul
investig
bone
marrow
output
newli
emerg
b
cell
assess
via
tcell
recombin
circl
trec
kappadelet
element
recombin
circl
krec
analysi
peripher
blood
expect
sibl
detect
krec
copi
peripher
blood
indic
sever
impair
b
cell
develop
trec
analysi
show
normal
result
bone
marrow
examin
younger
brother
also
show
complet
neg
krec
normal
trec
copi
krec
copi
absent
peripher
blood
father
well
krectrec
copi
normal
unaffect
mother
interestingli
dna
obtain
newborn
guthri
card
younger
brother
analyz
show
normal
amount
krectrec
copi
indic
impair
b
lymphocyt
develop
occur
postnat
defici
protean
diseas
broad
spectrum
symptom
patient
present
hematolog
abnorm
cytopenia
earlyonset
myeloid
malign
increas
suscept
opportunist
infect
recent
publish
cohort
patient
treat
nation
institut
health
nih
bethesda
usa
patient
sever
viral
infect
particularli
infect
hpv
present
recalcitr
wart
condylomata
andor
dysplasia
sever
herpesviru
infect
present
patient
recurr
herp
stomat
esophag
genit
infect
sever
varicella
case
cytomegaloviru
pneumonia
dissemin
diseas
interestingli
patient
persist
ebv
viremia
similar
patient
document
patient
ebvposit
skin
tumor
occur
infect
nontubercul
mycobacteria
seen
sever
bacteri
infect
observ
sever
invas
fungal
infect
patient
eighteen
percent
patient
show
increas
suscept
infect
addit
vascularlymphat
defect
venou
thrombosi
lymphedema
sensorineur
hear
loss
miscarriag
hypothyroid
found
pulmonari
involv
defici
frequent
involv
infect
pap
particularli
advanc
stage
diseas
nih
cohort
patient
diffus
ventilatori
defect
respect
pap
found
pulmonari
arteri
hypertens
patient
structur
abnorm
includ
nodul
reticular
ground
glass
opac
subpleur
bleb
crazi
pave
parasept
emphysema
similar
pictur
could
seen
patient
surprisingli
normal
pulmonari
function
test
result
patient
could
possibl
explain
local
afflict
pulmonari
tissu
infiltr
fibrot
tissu
decreas
elast
lung
parenchyma
howev
still
enough
normal
tissu
kept
static
volum
transfer
factor
normal
tabl
unfortun
possibl
compar
find
pediatr
patient
data
pulmonari
inflict
children
scarc
children
nih
cohort
data
pulmonari
function
test
present
median
age
test
year
rang
year
median
time
diseas
manifest
year
rang
year
children
suffer
myeloid
malign
four
chronic
infect
herpesvirus
mycobacteria
speci
document
mild
sever
diffus
defect
found
test
patient
two
children
bronchial
obstruct
seen
inform
structur
lung
chang
affect
children
provid
median
age
initi
present
nih
cohort
year
highli
variabl
rang
month
year
note
four
individu
appar
clinic
manifest
last
followup
rang
year
proport
patient
without
symptom
age
age
age
irrespect
type
genet
chang
phenotyp
vari
within
famili
significantli
fact
strongli
argu
substanti
impact
epigenet
infecti
environment
factor
diseas
manifest
effect
germlin
somat
mutat
gene
may
play
role
well
may
explain
variabl
symptom
three
individu
carri
mutat
within
index
famili
intrigu
issu
etiolog
chronic
diffus
parenchym
lung
tissu
chang
patient
absenc
respiratori
symptom
extens
investig
reveal
ebv
presenc
peripher
blood
well
pulmonari
tissu
without
specif
tissu
chang
clinic
appar
ebv
infect
eg
mononucleosislik
symptom
lymphoprolifer
patient
present
serolog
sign
acut
ebv
infect
wherea
pulmonari
chang
chronic
decis
role
ebv
pathogenesi
pulmonari
tissu
chang
patient
improb
possibl
repeat
mild
infect
environ
impair
regul
endotheli
nitric
oxid
synthetas
express
defect
phagocytosi
impair
gmcsf
signal
pulmonari
macrophag
play
role
pathogenesi
chronic
pulmonari
inflammatori
chang
poor
control
ebv
replic
result
persist
ebv
viremia
irrespect
lung
involv
known
phenomenon
defici
patient
shown
inabl
confin
viral
infect
patient
defici
correl
well
extent
cytopenia
name
lack
dc
nk
tcell
similarli
defect
antibodi
respons
advanc
stage
associ
b
cell
lymphopenia
howev
regard
possibl
oligogen
etiolog
immunodefici
defici
impact
gene
implic
ebv
control
consid
exclud
common
syndrom
xlink
lymphoprolif
diseas
type
caus
defect
adapt
protein
sap
involv
signal
cellcel
interact
molecul
implic
ebv
control
encompass
exampl
ubiquit
express
xiap
antiapoptot
function
multipl
signal
pathway
connect
surfac
molecul
import
intercellular
commun
nk
cell
activ
receptor
antibodydepend
cell
cytotox
minichromosom
mainten
crucial
nkcell
function
tcell
kinas
itk
serinethreonin
kinas
stk
magnesium
transport
indispens
tcell
receptor
signal
tcell
homeostasi
search
defect
patient
prompt
abnorm
leukocyt
lymphocyt
count
anoth
serum
marker
use
diagnost
well
monitor
diseas
progress
correl
cytopenia
stem
cell
growth
fmsrelat
tyrosin
kinas
ligand
ligand
shown
newborn
screen
use
krectrec
analysi
use
screen
defici
prognosi
individu
mutat
difficult
establish
due
high
clinic
variabl
incomplet
penetr
lack
close
phenotypegenotyp
correl
data
antibiot
eg
azithromycin
hpv
vaccin
recommend
prophylact
measur
use
steroid
immunosuppress
therapi
indic
exclus
immunodefici
dpld
prior
use
warrant
larg
proport
patient
develop
myeloid
malign
later
life
cur
therapi
allogen
hematopoiet
stem
cell
transplant
two
patient
defici
pulmonari
involv
transplant
advanc
md
report
profit
significantli
procedur
diffus
parenchym
lung
diseas
heterogen
group
disord
often
insidi
onset
symptom
underli
immunodefici
may
appar
immunolog
genet
workup
requir
particular
abnorm
peripher
leukocyt
count
reveal
demonstr
patient
aberr
immun
respons
common
respiratori
infect
may
result
diffus
lung
diseas
bronchial
bronchiolar
damag
signific
chronic
chang
pulmonari
parenchyma
fibrot
remodel
structur
chang
might
present
prior
sever
infect
diffus
parenchym
lung
diseas
may
becom
first
manifest
defici
earli
genet
diagnosi
critic
direct
clinic
manag
prophylaxi
transplant
famili
screen
written
inform
consent
obtain
patient
famili
public
case
report
accompani
imag
copi
written
consent
avail
review
editor
journal
